Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
Sanofi CSO Nestle exits. Pfizer names Citi analyst to chief strategy role. Acelyrin's founding CEO departs.
Max Bayer
,
Gabrielle Masson
May 10, 2024 8:30am
Sanofi CSO Frank Nestle is leaving
May 8, 2024 10:00am
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
Apr 25, 2024 2:35am
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Apr 23, 2024 10:43am
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Apr 23, 2024 2:23am
Sanofi cuts staff in Belgium as early-stage research dwindles
Apr 19, 2024 11:34am